BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Russo E, Fiorindi C, Giudici F, Amedei A. Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma. World J Hepatol 2022; 14(2): 372-385 [PMID: 35317185 DOI: 10.4254/wjh.v14.i2.372]
URL: https://www.wjgnet.com/1948-5182/full/v14/i2/372.htm
Number Citing Articles
1
Xiangdong Yan, Liuhui Bai, Ping Qi, Jin Lv, Xiaojing Song, Lei Zhang. Potential Effects of Regulating Intestinal Flora on Immunotherapy for Liver CancerInternational Journal of Molecular Sciences 2023; 24(14): 11387 doi: 10.3390/ijms241411387
2
Georgia Saxami, Evangelia Kerezoudi, Christos Eliopoulos, Dimitrios Arapoglou, Adamantini Kyriacou. The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of PrebioticsLife 2023; 13(10): 2023 doi: 10.3390/life13102023
3
Ayana R. Kumar, Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Lekshmi R. Nath, Daniela Calina, Javad Sharifi-Rad. Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advancesEuropean Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-02072-3
4
Susana G. Rodrigues, Schalk van der Merwe, Aleksander Krag, Reiner Wiest. Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseasesSeminars in Immunology 2024; 71: 101859 doi: 10.1016/j.smim.2023.101859
5
Nazanin Daneshpour. Bifidobacterium and the Immune System: A Key Player Against Gastrointestinal CancersJournal of Microbiota 2024; 1(3) doi: 10.5812/jmb-154264
6
Aun R. Shah, Sandeep Mukherjee. Impact of gut microbiome on immunotherapy resistance in hepatocellular carcinoma: a review articleHepatoma Research 2024;  doi: 10.20517/2394-5079.2024.76
7
Kuttiappan Anitha, Jamal Basha Dudekula, Neeraj Mishra, Kamal Dua, Shvetank Bhatt. Synbiotics for the Management of Cancer2023; : 175 doi: 10.1007/978-981-19-7550-9_8